Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Outcomes Following Macrolide Use in Kidney...
Journal article

Outcomes Following Macrolide Use in Kidney Transplant Recipients

Abstract

BACKGROUND: Calcineurin inhibitors (CNI; cyclosporine, tacrolimus) are critical for kidney transplant immunosuppression, but have multiple potential drug interactions, such as with macrolide antibiotics. Macrolide antibiotics (clarithromycin, erythromycin, and azithromycin) are often used to treat atypical infections. Clarithromycin and erythromycin inhibit CNI metabolism and increase the risk of CNI nephrotoxicity, while azithromycin does not.

Authors

Jeong R; Quinn RR; Lentine KL; Lloyd A; Ravani P; Hemmelgarn B; Braam B; Garg AX; Wen K; Wong-Chan A

Journal

Canadian Journal of Kidney Health and Disease, Vol. 6, ,

Publisher

SAGE Publications

Publication Date

1 2019

DOI

10.1177/2054358119830706

ISSN

2054-3581

Labels

Sustainable Development Goals (SDG)